Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0610
+0.0040 (7.02%)
Oct 22, 2026, 9:59 AM AEDT
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 69.77 million as of October 21, 2026. It is the 30,516th most valuable company in the world and the 698th biggest in Australia. Its market cap has increased by 54.32% in one year.
Market Cap
69.77M
Enterprise Value
60.95M
Revenue
3.45M
Global Rank
Country Rank
#698 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 69.77M, an increase of 1,118.88%. That is a compound annual growth rate of 9.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 69.77M | -21.00% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 123.08M |
| Recce Pharmaceuticals | 107.02M |
| Nyrada | 105.23M |
| Island Pharmaceuticals | 97.71M |
| LTR Pharma | 85.67M |
| Neurizon Therapeutics | 62.01M |
| Alterity Therapeutics | 61.86M |
| Arovella Therapeutics | 60.44M |